These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 29473719

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
    Das A, McGuire PG, Rangasamy S.
    Ophthalmology; 2015 Jul; 122(7):1375-94. PubMed ID: 25935789
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
    Urias EA, Urias GA, Monickaraj F, McGuire P, Das A.
    Vision Res; 2017 Oct; 139():221-227. PubMed ID: 28993218
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diabetic macular edema.
    Lang GE.
    Ophthalmologica; 2012 Oct; 227 Suppl 1():21-9. PubMed ID: 22517122
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diabetic Macular Edema: Options for Adjunct Therapy.
    Calvo P, Abadia B, Ferreras A, Ruiz-Moreno O, Verdes G, Pablo LE.
    Drugs; 2015 Sep; 75(13):1461-9. PubMed ID: 26242766
    [Abstract] [Full Text] [Related]

  • 12. Nonbiological pharmacotherapies for the treatment of diabetic macular edema.
    Agarwal A, Parriott J, Demirel S, Argo C, Sepah YJ, Do DV, Nguyen QD.
    Expert Opin Pharmacother; 2015 Sep; 16(17):2625-35. PubMed ID: 26523670
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
    Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, Dugel PU, Freund KB, Glassman AR, Kim JE, Martin DF, Pollack JS, Regillo CD, Rosenfeld PJ, Schachat AP, Wells JA, American Society of Retina Specialists Anti-VEGF for Diabetic Macular Edema Comparative Effectiveness Panel.
    JAMA Ophthalmol; 2016 Jan; 134(1):95-9. PubMed ID: 26512939
    [Abstract] [Full Text] [Related]

  • 17. Anti-angiogenesis drugs in diabetic retinopathy.
    Jeganathan VS.
    Curr Pharm Biotechnol; 2011 Mar 01; 12(3):369-72. PubMed ID: 20939797
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.